TCIM
CRMD icon

TIAA CREF Investment Management’s CorMedix CRMD Stock Holding History

TIAA CREF Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-19,521
Closed -$259K – 3159
2016
Q1 		$259K Hold
19,521
– – ﹤0.01% 2938
2015
Q4 		$198K Hold
19,521
– – ﹤0.01% 3068
2015
Q3 		$194K Hold
19,521
– – ﹤0.01% 3045
2015
Q2 		$379K Buy
+19,521
New +$670K ﹤0.01% 3027

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

TIAA CREF Investment Management's CRMD Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of CorMedix (CRMD) in Q2 2016, closing a stake of 19,521 shares — an estimated $259K sold.

TIAA CREF Investment Management first reported a position in CRMD in Q2 2015 and held it in 4 quarters. The position peaked at $379K in Q2 2015. 47 funds tracked by Wall St. Rank hold CRMD as of Q2 2016.

  • TIAA CREF Investment Management reported no remaining CorMedix position as of Q2 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 19,521 CorMedix shares in Q2 2016, an estimated $259K.
  • TIAA CREF Investment Management first reported a position in CorMedix in Q2 2015 and held it in 4 quarters.
  • TIAA CREF Investment Management's CorMedix position peaked at $379K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held CorMedix as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.